AzTrials
AzTrials

Mental Health IssueRegain_SEENNCT04526743

Eating Behavior and Weight Trajectory After Bariatric Surgery

An observational study of Mental Health Issue and Eating Behavior, run by GOSEEN Obesity group of the Spanish Endocrinology Society at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Studying the mechanisms of weight regain (WR) may provide much needed insight into sustained obesity management. The aim of this five-year, prospective, multicenter study is to evaluate the association among eating patterns (specifically maladaptive behaviors), certain psychological variables and weight trajectory in… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Mental Health Issue, Eating Behavior
What is being tested?
Questionnaire
How many people
500 participants
Where
1 siteSpain
Study dates
1 Sep 2019to 1 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September 2020 to September 2021 and a control group of subjects with obesity not candidates to BS matched with the intervention group for age, sex and BMI prior to BS.

Who may be able to join

  • Candidate to primary BS from 09/2020 to 09/2021.
  • Subjects with obesity (>40 kg/m2) not candidates to BS.
  • Internet users.
  • Primary BS: LGBP and LSG.
  • Accept to participate in the study and provide signed informed consent

Who cannot join

  • Second time and/or revisional BS.
  • Pregnancy.
  • Presence of intellectual impairment impeding the administration of the psychometric tools.
  • Type 1 diabetes.
  • Dyslexia.

Trial locations and contacts

1 site in 1 country.

Lilliam Flores, PhD contact

0034658023562

lflores@clinic.cat

Spain1 site, 1 recruiting
  • Hospital Clinic

    Barcelona, 08036

    Lilliam Flores, PhD, 0034658023562, lflores@clinic.cat

    Lilliam Flores, PhD

    Recruiting

Other trials in Spain

About this study

Official title: Mental Health, Dysfunctional Eating Pattern and Weight Trajectory in Subjects Undergoing Bariatric Surgery

Studying the mechanisms of weight regain (WR) may provide much needed insight into sustained obesity management. The aim of this five-year, prospective, multicenter study is to evaluate the association among eating patterns (specifically maladaptive behaviors), certain psychological variables and weight trajectory in the short- and long-term after bariatric surgery (BS). The study will include 2 groups: 1.- Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September 2020 to September 2021. This group will be evaluated prior to surgery, at 4 months, 1 year, 3 years and 5 years after BS, and 2.- a control group of subjects with obesity not candidates to BS matched with the intervention group for age, sex and BMI prior to BS. They will be evaluated once. The primary variable will be: body weight: total weight lost (%), excess weight lost (%), total weight regained (%), excess of weight regain (%). Information regarding the psychological and behavioral variables will be collected using questionnaires that have been validated in our setting and will be completed by the patients themselves online.

Read the detailed description

The objective of this study is to evaluate the association among eating patterns (specifically maladaptive behaviors), certain psychological variables and weight trajectory in the short- and long-term after bariatric surgery.

Design: Five-year, prospective, multicenter study.

The study will include 2 groups:

  1. Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September 2020 to September 2021.The subjects of this group will be followed prior to BS, at 4 months, 1 year, 3 years and 5 years after BS.
  2. A control group of subjects with obesity not candidates to BS matched with the intervention group for age, sex and BMI prior to BS. They will be evaluated once.

Inclusion criteria:

  • Candidates to primary BS from 09/2020 to 09/2021.
  • Subjects with obesity (>40 kg/m2) not candidates to BS.
  • Internet users.
  • Primary BS: LGBP and LSG.
  • Accept to participate in the study and provide signed informed consent.

Exclusion criteria:

  • Second time and/or revisional BS.
  • Pregnancy.
  • Presence of intellectual impairment impeding the administration of the psychometric tools.
  • Type 1 diabetes.
  • Dyslexia. Weight variables: definitions.
  1. The different weight variables will be calculated as follows:
  • Weight lost (kg): Pre-BS weight - weight at nadir.
  • Current weight lost: Pre-BS weight - current weight.
  • Ideal weight: weight corresponding to a BMI = 25 kg/m2.
  • Excess weight lost (%): (Pre-BS weight - current weight)/excess weight [(pre- BS weight - ideal weight) x 100].
  • Total weight lost (%): (pre-Bs weight - current weight/pre-BS weight) x 100.
  1. To study WR the following variables will be calculated:
  • Total WR (%): (100/(pre-BS weight - weight at nadir)) * weight regained (kg).
  • Excess WR (EWR %): [(current weight - weight at nadir)/excess weight] x 100
  • Weight regained (Kg): current weight - weight at nadir.

Excess weight lost > 50%, total weight lost > 25% and EWR > 15% will be considered as significant.

Information regarding the psychological and behavioral variables will be collected using questionnaires that have been validated in our setting and will be completed by the patients themselves online.

To assess hedonic response to the foods, the following questionnaires will be used:

  • The subscale of external signal-triggered eating of the Dutch Eating Behavior Questionnaire (DEBQ) that includes 10 questions.
  • A food addiction questionnaire (Yale Food Addiction Scale II) with 25 questions.
  • The Bulimia Investigatory Test Edinburgh (BITE) made up of 2 subscales of symptoms and severity including 33 questions.
  • There will also be questions related to snacking/nibbling.

The following will be used to assess mood state, stress and negative emotions:

  • Dutch Eating Behavior Questionnaire (DEBQ) which evaluates eating styles and takes into account 3 subscales: external, restrained (10), and emotional eating (13) including a total of 23 questions.
  • Positive and Negative Affect Schedule (PANAS) to assess the positive and negative effects of emotional experiences including 20 questions.
  • Barrat Impulsivity Scale (BIS-11) which evaluates impulsive tendencies in 3 dimensions: cognitive, motor and lack of planning and includes 30 questions.
  • The consumption of toxic substances will be determined using the following questionnaires: Alcohol Use Disorders Identification Test (AUDIT-4) including 4 questions in which data on the frequency and quantity of alcohol consumed will be obtained, and the Fagerström Nicotine Dependence Scale including 6 questions.
  • The Eysenck Personality Questionnaire - Revised (EPQ-R) with only the dimension of neuroticism including 23 questions.

These variables will be considered as confounding psychological variables and will, therefore, be controlled by statistical tests.

  • Depression: evaluated with the Hospital Anxiety and Depression Scale (HADS) including 14 questions.
  • Perceived economic status, assessed using a visual analog scale of 10 cms with markings at 0, 5, 10 cm without numbers.
  • The International Physical Activity Questionnaire (IPAQ) including 7 questions to assess physical activity.
  • Social support evaluated by the evaluation protocol using the English Longitudinal Study of Aging study. APGAR (including 5 questions).
  • Quality of life evaluated using the Impact of Weight on the Quality of Life - Lite (IWQOL-lite) questionnaire including 31 questions.

Evaluation of food intake: The patients will also complete a registry of foods and drinks consumed over 3 days including a weekend day. It should include the type of food, cooking method, and portion size or weight. Afterwards, the total intake and by macronutrients will be analyzed with the Diet Source software (Nestle Health Science. V4.0).

Primary variable:

Body weight: total weight lost (%), excess weight lost (%), total weight regained (%), excess of weight regain (%).

Data collection:

Additional information on demographic and anthropometric characteristics and on comorbidities both prior to BS and their evolution over time will be collected in an Excel datasheet designed with this objective.

Sample size The study will include 445 patients undergoing BS. It is estimated that the percentage of losses to follow-up at 5 years will not be greater than 10% and thus, at least 400 patients must achieve complete follow-up. This sample size will have a statistical power of 80% for detecting an effect size, that is, differences divided by the standard deviation of at least 0.281. Additionally, 100 controls not undergoing BS will be included and matched for age, gender and BMI with the objective of standardizing the values in the scales. The ratio will be 1:4 for controls and patients undergoing BS, respectively.

Statistical analysis. The design and statistical analysis of the present study meet the recommendations of consensus documents in the literature, especially the TRIPOD statement. A statistical analysis plan (SAP) will be elaborated prior to finalization of data collection and will provide an in-depth description of the statistical methods to be used, the tables and figures that will be included in the statistical report as well as the strategy to follow in the case of missing values, and multiplicity adapted to regulatory and scientific recommendations.

Being tested
Questionnaire
Keywords
obesity, eating behaviour, weight regained, bariatric surgery
Medical subject headings
Feeding Behavior, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireBehavioural

    Psychological and behavioral variables will be collected using questionnaires that have been validated in our setting and will be completed by the patients themselves online.

Study groups in NCT04526743
Study groupRoleWhat they receive
BS patientsCandidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September 2020 to September 2021. Patients will be evaluated prior to BS and at 4 months, 1, 3 and 5 years after BS.
Receives: Behavioral: Questionnaire
no BS patientA control group of subjects with obesity not candidates to BS matched with the intervention group for age, sex and BMI prior to BS. Patients will be evaluated once.
Receives: Behavioral: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total weight lost percent (%).

    Total weight lost > 25 percent.

    Measured: 5 years.

  2. Excess weight lost: percent (%),

    Excess weight lost > 50 percent

    Measured: 5 years

  3. Total weight regained: percent (%)

    Total weight regained > 15%

    Measured: 5 years

  4. Excess of weight regain: percent (%).

    EWR > 15 percent will be considered as significant

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2020
  2. Study start1 Sep 2019
  3. Primary completion1 Sep 2021 (estimated)
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04526743
Sponsor's protocol ID
HCB/2019/0090
Acronym
Regain_SEEN
Status last verified
Aug 2020
First submitted
8 May 2020
Last updated
26 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mental Health Issue and Eating Behavior, run by GOSEEN Obesity group of the Spanish Endocrinology Society at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lilliam Flores, PhD (0034658023562, lflores@clinic.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total weight lost percent (%). (time frame: 5 years.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in